---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042117"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:04:53.712081+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Lipocine extends stockholder rights plan to October 2027; amends preferred stock certificate

## Summary
- Third Amended and Restated Rights Agreement extends expiration to October 22, 2027 (from November 1, 2024).
- No material changes to the plan; Rights remain exercisable at $30.24 per one-thousandth of Series A Preferred.
- Certificate of Amendment filed to reflect impact of May 2023 reverse stock split on preferred stock designation.
- Rights become exercisable if a person acquires 15%+ of common stock; designed to deter coercive takeovers.

## SEC filing metadata
- accession: 0001493152-24-042117
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/0001493152-24-042117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042117
- JSON: https://secwatch.observer/filing/0001493152-24-042117.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042117.txt

## Key facts
- Governance Changes
  Lipocine Inc.: Filed Certificate of Amendment to Certificate of Designation of Series A Junior Participating Preferred Stock to reflect reverse stock split (effective 2024-10-22).
  - Change: charter amendment
  - Effective: 2024-10-22
  source text: On October 22, 2024, in connection with the adoption of the Third Amended and Restated Stockholder Rights Agreement, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Certificate of Designation of the Series A Junior Participating Preferred Stock (the “Certificate of Amendment”) to reflect the impact of the Company’s reverse stock split effected on May 11, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/0001493152-24-042117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.